You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vaccine adjuvant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine

Recruiting
  • Hepatitis B
  • GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
  • +4 more
  • Cambridge, United Kingdom
    GSK Investigational Site
Jan 12, 2023

Typhoid Fever Trial (TYP04A Low Dose without adjuvant investigational vaccine, TYP04B Full Dose without adjuvant investigational

Not yet recruiting
  • Typhoid Fever
  • TYP04A Low Dose without adjuvant investigational vaccine
  • +5 more
  • (no location specified)
Nov 4, 2022

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01 in combination with standard adjuvant therapy
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)

Not yet recruiting
  • Advanced Ovarian Cancer
  • AST-201
  • +4 more
  • Seattle, Washington
    University of Washington
Mar 20, 2023

Shigellosis, Bacillary Dysentery Trial in Leiden (2.5 µg InvaplexAR-Detox, 10 µg InvaplexAR-Detox, 0.1 µg of dmLT)

Not yet recruiting
  • Shigellosis
  • Bacillary Dysentery
  • 2.5 μg InvaplexAR-Detox
  • +3 more
  • Leiden, Netherlands
    Leiden University Medical Center
Jul 26, 2023

Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)

Not yet recruiting
  • Healthy
  • H107e
  • +10 more
  • Pretoria, Gauteng, South Africa
    Aurum Institute
Sep 24, 2023

COVID-19 Trial in United States (NVX-CoV2373, SARS-CoV-2 rS antigen/Matrix-M Adjuvant)

Active, not recruiting
  • COVID-19
  • NVX-CoV2373
  • SARS-CoV-2 rS antigen/Matrix-M Adjuvant
  • Austin, Texas
  • +4 more
May 16, 2023

Plague, Pneumonic, Plague, Vaccine-Preventable Diseases Trial in United States (rF1V vaccine and CpG 1018® adjuvant, rF1V

Recruiting
  • Plague, Pneumonic
  • +2 more
  • rF1V vaccine and CpG 1018® adjuvant
  • rF1V vaccine
  • Huntsville, Alabama
  • +4 more
Aug 16, 2022

Cholera Vaccination Reaction Trial in Seoul (OSP:rTTHc Cholera Conjugate Vaccine Cohort A, OSP:rTTHc Cholera Conjugate Vaccine

Recruiting
  • Cholera Vaccination Reaction
  • OSP:rTTHc Cholera Conjugate Vaccine Cohort A
  • +8 more
  • Seoul, Korea, Republic of
  • +2 more
Nov 30, 2022

Malaria, Plasmodium Falciparum Trial in Oxford (Pfs48/45 in Matrix-M)

Recruiting
  • Malaria
  • Plasmodium Falciparum
  • Pfs48/45 in Matrix-M
  • Oxford, United Kingdom
    CCVTM, University of Oxford
Dec 13, 2022

Pancreas Cancer Trial in United States (TG01 Vaccine, QS-21, Balstilimab)

Recruiting
  • Pancreas Cancer
  • TG01 Vaccine
  • +2 more
  • Fairway, Kansas
  • +4 more
Jan 30, 2023

Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)

Not yet recruiting
  • Influenza, Human
  • FLU Q-PAN H5N8 Formulation 1
  • +3 more
  • (no location specified)
Jul 27, 2023

Herpes Zoster Trial in Xinxiang (Low Dose Recombinant Herpes Zoster Vaccine (CHO cells), High Dose Recombinant Herpes Zoster

Active, not recruiting
  • Herpes Zoster
  • Low Dose Recombinant Herpes Zoster Vaccine (CHO cells)
  • +5 more
  • Xinxiang, Henan, China
    Yanjin District Center for Disease Control and Prevention
Feb 1, 2023

Influenza Trial in Raleigh, Rocky Mount, Statesville (NanoFlu, Fluzone HD - Day 0, Fluzone HD - Day 21)

Completed
Has Results
  • Influenza
  • NanoFlu
  • +3 more
  • Raleigh, North Carolina
  • +2 more
Nov 29, 2022

Influenza Trial (Unadjuvanted seasonal influenza vaccine, SWE adjuvant mixed with unadjuvanted seasonal influenza vaccine

Not yet recruiting
  • Influenza
  • Unadjuvanted seasonal influenza vaccine
  • +2 more
  • (no location specified)
Mar 16, 2022

COVID-19 Trial in Bloemfontein, Pretoria, Soweto (Candidate vaccine, SCB-2020S, Candidate vaccine, SCB-2019, Squalene based

Active, not recruiting
  • COVID-19
  • Candidate vaccine, SCB-2020S
  • +3 more
  • Bloemfontein, South Africa
  • +2 more
Oct 18, 2022

Healthcare Worker, Hepatitis B Vaccine, Nonresponder Trial in Madison (Recombinant hepatitis B vaccine with CpG adjuvant)

Recruiting
  • Healthcare Worker, Hepatitis B Vaccine, Nonresponder
  • Recombinant hepatitis B vaccine with CpG adjuvant
  • Madison, Wisconsin
    University of Wisconsin
Jul 5, 2022

Schistosomiasis Mansoni, Schistosomiasis Haematobium, Vaccination; Infection Trial in Saint Louis (Sm14 recombinant vaccine+

Recruiting
  • Schistosomiasis Mansoni
  • +2 more
  • Sm14 recombinant vaccine+ GLA-SE adjuvant
  • Saint Louis, Senegal
    Biomedical Research Center EPLS
Dec 13, 2022

Tuberculosis Trial in Wuhan (Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02), Low-dose adjuvant for

Completed
  • Tuberculosis
  • Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
  • +2 more
  • Wuhan, Hubei, China
    Wuhan Infectious Disease Hospital
Sep 2, 2022

Tuberculosis Trial in Changsha (Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02), High-dose freeze-dried

Recruiting
  • Tuberculosis
  • Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
  • +3 more
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Sep 2, 2022

NSCLC, Non-Small Cell Lung Carcinoma, NSCLC Trial run by the National Cancer Institute (NCI) (biological, drug, device)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Montanide (Registered Trademark) ISA-51 VG Adjuvant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Pneumococcal Disease Trial in Hialeah, Elkridge, San Antonio (Low dose multivalent pneumococcal conjugate vaccine formulation A,

Recruiting
  • Pneumococcal Disease
  • Low dose multivalent pneumococcal conjugate vaccine formulation A
  • +3 more
  • Hialeah, Florida
  • +2 more
Apr 27, 2023

Pancreatic Adenocarcinoma Trial in Lausanne (Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC

Recruiting
  • Pancreatic Adenocarcinoma
  • Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC vaccine)
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jun 23, 2022

Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,

Active, not recruiting
  • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Incomplete Freund's Adjuvant
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 12, 2022